Fox Corporation (Class A) vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

Fox Corporation (Class A) leads in AI visibility (93 vs 90)

Fox Corporation (Class A)

LeaderCommunications

Enterprise

New York media (NASDAQ: FOXA voting) ~$14.7B FY2024 revenue; Fox News #1 cable news, Tubi 70M+ monthly users FAST streaming, Fox One streaming launch for cord-cutters competing with CNN/Warner and NBC.

AI VisibilityBeta
Overall Score
A93
Category Rank
#146 of 290
AI Consensus
78%
Trend
down
Per Platform
ChatGPT
87
Perplexity
91
Gemini
86

About

Fox Corporation is a New York City, New York-based television broadcasting, cable news, and sports media company — its Class A voting shares publicly traded on NASDAQ (NASDAQ: FOXA) as an S&P 500 Communication Services component — operating the Fox News Channel (the top-rated US cable news network), Fox Business Network, the Fox broadcast television network (affiliate stations reaching 99% of US households), Fox Sports, and Tubi (the largest free ad-supported streaming service in the US) through approximately 9,000 employees. In fiscal year 2024 (ending June 2024), Fox Corporation reported total revenue of approximately $14.7 billion, with affiliate fee revenue (cable providers paying per-subscriber fees for Fox News and Fox Business carriage) and advertising revenue from Fox News Channel and Fox broadcast sporting events (NFL, MLB, NASCAR, UFC) as the primary revenue drivers. Fox Corporation was formed in 2019 when Rupert Murdoch's 21st Century Fox sold its entertainment film and TV studios to Walt Disney Company for $71.3 billion — retaining the news and sports broadcast assets as the new Fox Corporation. Lachlan Murdoch serves as Executive Chairman and CEO. Fox One, the company's streaming service targeting cord-cutters, officially launched to provide access to Fox broadcast network programming and cable channels for subscribers who have cancelled traditional cable.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

93
Overall Score
90
#146
Category Rank
#9
78
AI Consensus
60
down
Trend
stable
87
ChatGPT
99
91
Perplexity
99
86
Gemini
83
89
Claude
96
95
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.